Salih Demir

4PUBLICATIONS
7CO-AUTHORS
Molecular targetsHaematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 26, 2026
Preclinical Drug-Response Profiling Identifies BMI1 Inhibition as a Therapeutic Option for Hepatoblastoma.

|May 27, 2026
Proteasome Targeting with Carfilzomib Induces Reactive Oxygen Species-Mediated Apoptosis in Hepatoblastoma.

|Apr 26, 2025
Targeting HSP90 with Ganetespib to Induce CDK1 Degradation and Promote Cell Death in Hepatoblastoma.

Lea Amelie Jung, Salih Demir, Alina Hotes

|Jan 29, 2024
Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma.

Salih Demir, Negin Razizadeh, Emilie Indersie

Pageof 1

Frequent Collaborators

4 joint publications

Stefano Cairo

4 joint publications

Roland Kappler

2 joint publications

Emilie Indersie

1 joint publications

Eiso Hiyama